Literature DB >> 24192023

Cerebral blood flow in nondemented elderly subjects with extensive deep white matter lesions on magnetic resonance imaging.

H Yao1, T Yuzuriha, K Fukuda, T Matsumoto, S Ibayashi, H Uchimura, M Fujishima.   

Abstract

Our previous study showed that deep white matter lesions (DWML) were associated with subtle cognitive decline in community-dwelling elderly people. However, even extensive (EXT)-DWML, found in 7 (4%) of 178 subjects aged 60 years or older, did not cause dementia. The purpose of the present study was to investigate brain circulation in nondemented elderly subjects with EXT-DWML. We compared cerebral blood flow in the deep white matter and frontal cortex between 5 subjects with EXT-DWML and 5 without such lesions, using a xenon-enhanced computed tomography (CT) method. Although the difference of deep white matter findings on magnetic resonance imaging (MRI) was the greatest possible (i.e., extensive v no or minimum lesions), cerebral blood flow values in anterior deep white matter and frontal cortex were 21.4 ± 5.3 standard deviation (SD) mL/100 g/minute and 42.7 ± 4.1, respectively, in subjects with extensive lesions, which were not significantly different from 24.3 ± 4.3 and 44.0 ± 7.1 in subjects without DWML. The present study suggests that EXT-DWML in nondemented elderly individuals do not necessarily indicate apparent hypoperfusion or marked cognitive decline.
Copyright © 2000 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2000        PMID: 24192023     DOI: 10.1053/jscd.2000.7218

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  1 in total

Review 1.  Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Authors:  Yulu Shi; Michael J Thrippleton; Stephen D Makin; Ian Marshall; Mirjam I Geerlings; Anton J M de Craen; Mark A van Buchem; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-05       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.